Growth Metrics

Insulet (PODD) Shares Outstanding (Weighted Average) (2010 - 2026)

Insulet posted quarterly Shares Outstanding (Weighted Average) of $70.0 million for Q1 2026, little changed year-on-year from $70.3 million in Q1 2025, and down 0.51% on a QoQ basis from $70.3 million in Q4 2025.

Insulet (PODD) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $70.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.41% year-over-year to $70.0 million; the trailing twelve-month figure through Mar 2026 stood at $70.0 million (changed 0.41% YoY), and the FY2025 full-year result was $70.3 million, changed 0.39% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $70.0 million, down from $70.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $70.4 million in Q2 2025 and bottomed at $69.3 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $70.0 million (2024), against an average of $69.9 million.
  • The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) climbed 4.75%; it then declined 0.41% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $69.4 million in 2022, then advanced by 0.54% to $69.8 million in 2023, then advanced by 0.47% to $70.1 million in 2024, then gained by 0.39% to $70.3 million in 2025, then decreased by 0.51% to $70.0 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $70.0 million (Q1 2026), $70.3 million (Q4 2025), and $70.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.74 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 382.90 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 456.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 98.20 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 69.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 69.99 Mn
Dec 31, 2025 70.35 Mn
Sep 30, 2025 70.34 Mn
Jun 30, 2025 70.39 Mn
Mar 31, 2025 70.27 Mn
Dec 31, 2024 70.08 Mn
Sep 30, 2024 70.12 Mn
Jun 30, 2024 70.06 Mn
Mar 31, 2024 69.96 Mn
Dec 31, 2023 69.75 Mn
Sep 30, 2023 69.72 Mn
Jun 30, 2023 69.74 Mn
Mar 31, 2023 69.58 Mn
Dec 31, 2022 69.38 Mn
Sep 30, 2022 69.34 Mn
Jun 30, 2022 69.31 Mn
Mar 31, 2022 69.25 Mn
Dec 31, 2021 67.70 Mn
Sep 30, 2021 67.24 Mn
Jun 30, 2021 66.41 Mn
Mar 31, 2021 66.11 Mn
Dec 31, 2020 64.74 Mn
Sep 30, 2020 64.33 Mn
Jun 30, 2020 64.37 Mn
Mar 31, 2020 62.88 Mn
Dec 31, 2019 60.59 Mn
Sep 30, 2019 60.74 Mn
Jun 30, 2019 59.60 Mn
Mar 31, 2019 59.36 Mn
Dec 31, 2018 58.86 Mn
Sep 30, 2018 59.02 Mn
Jun 30, 2018 58.66 Mn
Mar 31, 2018 58.48 Mn
Dec 31, 2017 58.00 Mn
Sep 30, 2017 57.92 Mn
Jun 30, 2017 57.98 Mn
Mar 31, 2017 57.69 Mn
Dec 31, 2016 57.25 Mn
Sep 30, 2016 57.34 Mn
Jun 30, 2016 57.11 Mn
Mar 31, 2016 57.03 Mn
Dec 31, 2015 56.79 Mn
Sep 30, 2015 56.90 Mn
Jun 30, 2015 56.65 Mn
Mar 31, 2015 56.50 Mn
Dec 31, 2014 55.63 Mn
Sep 30, 2014 55.82 Mn
Jun 30, 2014 55.26 Mn
Mar 31, 2014 55.09 Mn
Dec 31, 2013 54.01 Mn
Sep 30, 2013 53.79 Mn
Jun 30, 2013 53.45 Mn
Mar 31, 2013 53.05 Mn
Dec 31, 2012 47.92 Mn
Sep 30, 2012 47.83 Mn
Jun 30, 2012 47.72 Mn
Mar 31, 2012 47.61 Mn
Dec 31, 2011 46.69 Mn
Sep 30, 2011 46.44 Mn
Jun 30, 2011 46.00 Mn
Mar 31, 2011 45.58 Mn
Dec 31, 2010 39.61 Mn